Abnormal prostate development in C3(1)-bcl-2 transgenic mice

Prostate

Volumn 32, Issue 1, 1997, Pages 16-26

  Zhang, Xuejun ^a   Chen, Min Wei ^a   Ng, Albert ^a   Ng, Po Ying ^a   Lee, Chung ^b   Rubin, Mark ^a   Olsson, Carl A ^a   Buttyan, Ralph ^a  

^a The New York Presbyterian Hospital   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; bcl 2; Prostate gland; Prostate steroid binding protein; Transgenic mice

Indexed keywords

PROTEIN BCL 2;

ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELLULAR DISTRIBUTION; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0030995015     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970615)32:1<16::AID-PROS3>3.0.CO;2-A     Document Type: Article

References (26)

1. McNeal J: Pathology of benign prostatic hyperplasia: Insight into etiology. Urol Clin North Am 17:477-496, 1990.
2. Catalona WJ: Management of cancer of the prostate. N Engl J Med 232:335-336, 1995.
3. Coffey DS, Walsh PC: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17:461-475, 1990.
4. Pollard M, Luckert PH, Snyder DL: The promotional effect of testosterone on induction of prostate cancer in MNU-sensitized L-W rats. Cancer Lett 45:209-212, 1989.
5. Bosland MC, Prinsen MK: Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz (a) anthracene, and 3,2′-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res 50: 691-699, 1990.
6. Maroulakou I, Anver M, Garrett L, Green JE: Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 194:11236-11240, 1994.
7. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443, 1995.
8. Colomel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R: Detection of apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390-400, 1993.
9. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992.
10. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R: Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55:4438-4445, 1995.
11. Buttyan R, Slawin K: Rodent models for targeted oncogenesis of the prostate gland. Cancer Metastasis Rev 12:11-19, 1993.
12. Hurst HC, Parker MG: Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J 2:769-774, 1983.
13. Parker MG, White R, Hurst H, Needham M, Tilly R: Prostatic steroid-bind protein: Isolation and characterization of C3 genes. J Biol Chem 258:12-15, 1983.
14. Hockenberry DM, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990.
15. Hogan B, Costantini F, Lacy E: "Manipulating the Mouse Embryo." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1986.
16. Sambrook JE, Fritsch J, Maniatis T: "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
17. Chen S, Even GA: A simple screening method for transgenic mice using the polymerase chain reaction. Biotechniques 8:32-34, 1990.
18. Zhang X, Colombel M, Raffo A, Buttyan R: Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate gland. Biochem Biophys Res Commun 198:1189-1194, 1994.
19. Heyns W, Peeters B, Mous J, Bossyns D, Rombauts W, de Moor P: Prostatic binding protein and its hormonal regulation. Prog Clin Biol Res 75:339-350, 1981.
20. Tan JA, Marschke KB, Ho KC, Perry ST, Wilson EM, French FS: Response elements of the androgen-regulated C3 gene. J Biol Chem 267:4456-4466, 1992.
21. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN: Bcl-2/ Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Can Biol 4:327-332, 1993.
22. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6, 1994.
23. Tsujimoto Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443, 1985.
24. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: Bcl-2 in normal human breast and carcinoma: Association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br J Cancer 691:135-139, 1994.
25. Chung LW: The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 23:33-42, 1995.
26. Berchem G, Cardillo M, Tarkington MA, Vicker C, Tehan TJ, Ortega LG, Saini N, Patterson RH, Lage J, Gelman EP: Bcl-2 and apoptosis in benign and malignant human prostate neoplasia after acute androgen withdrawal. Cancer Res 37:243, 1996.